Back to Results
First PageMeta Content
TA Associates / Merck & Co. / Readington / New Jersey / Schering-Plough / Venture capital / Pharmaceutical industry / Business / Polaris Venture Partners / Rofecoxib / Dow Jones Industrial Average / Pharmacology / Pharmaceutical sciences


FRIDAY, NOVEMBER 16, 2007 Painkiller gain Investors pump funds into pain management innovation by Ryan McBride Mass High Tech
Add to Reading List

Document Date: 2008-03-25 08:52:14

Open Document

File Size: 146,92 KB

Share Result on Facebook

City

Boston / Pittsburgh / Cambridge / /

Company

Hydra Biosciences Inc. / Logical / Oppenheimer & Co. Inc. / PricewaterhouseCoopers / Thomson Financial / Pfizer Inc. / Kathy Chapman Hydra Biosciences / Merck / New Jerseybased Merck & Co. Inc. / Waltham’s Logical Therapeutics Inc. / SV Life Sciences / Polaris Venture Partners / Advanced Technology Ventures / Eli Lilly & Co. / NeurAxon Inc. / Boston’s Solace Pharmaceuticals Inc. / /

Country

United States / Canada / /

Currency

USD / /

Event

Business Partnership / Funding / /

IndustryTerm

drug makers / venture capital / pharmaceutical industry / web use / venture capital going / anti-pain technologies / anti-pain technology / drug giants / pharmaceutical firms / /

MedicalCondition

extreme aches / chronic pain / arthritis / migraines / pain / pains / inflammation / /

MedicalTreatment

pain management / /

Organization

National Venture Capital Association / /

Person

Russell Herndon / Kevin Bitterman / Scott Henry / Jean George / /

/

Position

general partner / pharmaceutical analyst / CEO / president and CEO / /

Product

Vioxx / /

ProvinceOrState

Massachusetts / /

Region

New England / /

Technology

anti-pain technology / developing anti-pain technologies / drug development / /

SocialTag